Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 255 participants.
Also called NCT01951001
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 255 participants
- Registry
-
NCT01951001
-
- Other papers using this trial's data
- Pharmacodynamic Profile and Prevalence of Bleeding Episode in East Asian Patients with Acute Coronary Syndromes Treated with Prasugrel Standard-Dose versus De-escalation Strategy: A Randomized A-MATCH Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01951001. Randomized; no masking; primary purpose treatment. Start 2013-07 (actual); primary completion 2015-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome
- Condition
- Acute Coronary Syndrome
- Condition
- Platelet Thrombus
- Condition
- Bleeding
- Intervention (Drug)
- Prasugrel
- Lead sponsor
- Gyeongsang National University Hospital
Record details
- Record id
cardio:ct-nct01951001- Content hash
e05d38f9a466a08aea82287de85f33e0009f2084d23099e81fdd62be1b7f24be